Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-25-055292
Filing Date
2025-06-18
Accepted
2025-06-17 18:02:33
Documents
74

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 ea0245215-s1a3_lomond.htm   iXBRL S-1/A 2811691
2 CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea024521501ex23-1_lomond.htm EX-23.1 1939
3 CALCULATION OF FILING FEE ea024521501ex-fee_lomond.htm EX-FILING FEES 12273
9 GRAPHIC image_001.jpg GRAPHIC 31064
10 GRAPHIC image_002.jpg GRAPHIC 69775
11 GRAPHIC image_003.jpg GRAPHIC 51077
12 GRAPHIC image_004.jpg GRAPHIC 28111
13 GRAPHIC image_005.jpg GRAPHIC 25752
14 GRAPHIC image_006.jpg GRAPHIC 46690
15 GRAPHIC image_007.jpg GRAPHIC 47612
16 GRAPHIC image_008.jpg GRAPHIC 31707
17 GRAPHIC image_009.jpg GRAPHIC 29294
18 GRAPHIC image_010.jpg GRAPHIC 17121
19 GRAPHIC image_011.jpg GRAPHIC 116644
20 GRAPHIC image_012.jpg GRAPHIC 123981
21 GRAPHIC image_013.jpg GRAPHIC 74553
  Complete submission text file 0001213900-25-055292.txt   9534023

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cik0001900520-20250331.xsd EX-101.SCH 46330
5 XBRL CALCULATION FILE cik0001900520-20250331_cal.xml EX-101.CAL 41488
6 XBRL DEFINITION FILE cik0001900520-20250331_def.xml EX-101.DEF 253052
7 XBRL LABEL FILE cik0001900520-20250331_lab.xml EX-101.LAB 441389
8 XBRL PRESENTATION FILE cik0001900520-20250331_pre.xml EX-101.PRE 272330
78 EXTRACTED XBRL INSTANCE DOCUMENT ea0245215-s1a3_lomond_htm.xml XML 807896
Mailing Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901
Business Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901 561 464 2841
Lomond Therapeutics Holdings, Inc. (Filer) CIK: 0001900520 (see all company filings)

EIN.: 872959575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-283508 | Film No.: 251054561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)